Provivi
PrivateLast Round
Early Stage
VC
Apr 7, 2026
Total Funding Raised
$260.25M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Provivi is an agtech company that develops pheromone-based insect control solutions for crop protection.
Sector
Frontier & Industrial Tech
Verticals
Biotechnology, Sustainable Materials, Clean Manufacturing
Business Model
B2B
Customer Profile
Hardware Sales, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Provivi Comparables
Compare Provivi with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| ISCA | 83% | |
| M2i Life Sciences | 82% | |
| FMC Corporation | 80% | |
Provivi Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Early Stage VC | Apr 7, 2026 | ||||
| VC Round | Aug 19, 2024 | ||||
| Series C Extension | Feb 23, 2021 | ||||
| Series C Extension | Dec 22, 2020 | ||||
| Debt | Jun 16, 2020 | ||||
Series C | Oct 15, 2019 |
Key People
Founding team and executive leadership
Provivi Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Xeraya Capital | Series A |
| Temasek | Series C Extension, Series C |
| Kairos Ventures | Series A, Series C, Series C Extension, Series B, VC Round |
| Tybourne Capital Management | Series C Extension, Series C |
| Kairos Ventures | Series C, Series A, Seed, Series C Extension, VC Round, Series B |
| The Bill & Melinda Gates Foundation Trust | Series C Extension |
| Horizon Technology Finance Corporation | Debt |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 25, 2026
Monthly visitors increased 38% MoM.
- Apr 7, 2026
$25.5M raised in early stage VC funding.
Provivi Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Provivi's valuation, stock price, and market status.